Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
NCT07494084Phase 4Recruiting
- Sponsor
- Washington State University
- Start
- Jul 2026
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone, metyrapone in insulin resistance (IR), sponsored by Washington State University. Started Jul 2026; status: recruiting.
02
Drugs
hydrocortisonemetyrapone
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT07494084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07494084.